These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25883645)

  • 1. Estimation of an optimal chemotherapy utilisation rate for upper gastrointestinal cancers: setting an evidence-based benchmark for the best-quality cancer care.
    Ng W; Jacob S; Delaney G; Do V; Barton M
    Gastroenterol Res Pract; 2015; 2015():753480. PubMed ID: 25883645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of an optimal chemotherapy utilisation rate for breast cancer: setting an evidence-based benchmark for the best-quality cancer care.
    Ng W; Delaney GP; Jacob S; Barton MB
    Eur J Cancer; 2010 Mar; 46(4):703-12. PubMed ID: 20034784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of an optimal chemotherapy utilisation rate for cancer: setting an evidence-based benchmark for quality cancer care.
    Jacob SA; Ng WL; Do V
    Clin Oncol (R Coll Radiol); 2015 Feb; 27(2):77-82. PubMed ID: 25455844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of an optimal chemotherapy utilisation rate for lung cancer: an evidence-based benchmark for cancer care.
    Jacob S; Hovey E; Ng W; Vinod S; Delaney GP; Barton MB
    Lung Cancer; 2010 Sep; 69(3):307-14. PubMed ID: 20080315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of an optimal chemotherapy utilisation rate for head and neck carcinoma: setting an evidence-based benchmark for the best-quality cancer care.
    Ng W; Jacob S; Delaney G; Barton M
    Eur J Cancer; 2009 Aug; 45(12):2150-9. PubMed ID: 19285857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of an optimal chemotherapy utilisation rate for colon cancer: an evidence-based benchmark for cancer care.
    Jacob S; Ng W; Asghari R; Delaney GP; Barton MB
    Eur J Cancer; 2009 Sep; 45(14):2503-9. PubMed ID: 19527926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia.
    Ghandourh W; Holloway L; Batumalai V; Chlap P; Field M; Jacob S
    Clin Transl Radiat Oncol; 2022 May; 34():7-14. PubMed ID: 35282142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of an optimal chemotherapy utilisation rate for primary malignant brain tumours: an evidence-based benchmark for cancer care.
    Jacob S; Ng W; Delaney GP; Barton MB
    Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):48-54. PubMed ID: 20951557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: a review of the evidence.
    Delaney G; Barton M; Jacob S
    Cancer; 2004 Aug; 101(4):657-70. PubMed ID: 15305395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of an optimal utilisation rate for palliative radiotherapy in newly diagnosed cancer patients.
    Jacob S; Wong K; Delaney GP; Adams P; Barton MB
    Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):56-64. PubMed ID: 19969443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy in rectal cancer: variation in utilization and development of an evidence-based benchmark rate of optimal chemotherapy utilization.
    Jacob S; Ng W; Asghari R; Delaney GP; Barton MB
    Clin Colorectal Cancer; 2011 Jun; 10(2):102-7. PubMed ID: 21859561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part II--carcinoma of the endometrium.
    Delaney G; Jacob S; Barton M
    Cancer; 2004 Aug; 101(4):682-92. PubMed ID: 15305397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of an evidence-based benchmark for the optimal endocrine therapy utilization rate in breast cancer.
    Fong A; Ng W; Barton MB; Delaney GP
    Breast; 2010 Oct; 19(5):345-9. PubMed ID: 20223666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of the optimal utilisation rates of radical prostatectomy, external beam radiotherapy and brachytherapy in the treatment of prostate cancer by a review of clinical practice guidelines.
    Thompson SR; Delaney GP; Jacob S; Shafiq J; Wong K; Hanna TP; Gabriel GS; Barton MB
    Radiother Oncol; 2016 Jan; 118(1):118-21. PubMed ID: 26776443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012.
    Barton MB; Jacob S; Shafiq J; Wong K; Thompson SR; Hanna TP; Delaney GP
    Radiother Oncol; 2014 Jul; 112(1):140-4. PubMed ID: 24833561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of the optimal brachytherapy utilisation rate in the treatment of vaginal cancer and comparison with patterns of care.
    Thompson SR; Delaney GP; Gabriel GS; Jacob S; Barton MB
    J Med Imaging Radiat Oncol; 2012 Aug; 56(4):483-9. PubMed ID: 22883660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: Results from two large cancer facilities.
    Kang YJ; O'Connell DL; Tan J; Lew JB; Demers A; Lotocki R; Kliewer EV; Hacker NF; Jackson M; Delaney GP; Barton M; Canfell K
    Cancer Epidemiol; 2015 Aug; 39(4):600-11. PubMed ID: 26004990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing treatment benchmarks for mammography-screened breast cancer population based on a review of evidence-based clinical guidelines.
    Delaney G; Shafiq J; Chappell G; Barton M
    Cancer; 2008 May; 112(9):1912-22. PubMed ID: 18318431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines.
    Delaney G; Jacob S; Featherstone C; Barton M
    Cancer; 2005 Sep; 104(6):1129-37. PubMed ID: 16080176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.